HEADER IMMUNE SYSTEM 23-DEC-11 3V95 TITLE CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC AND IGG1 TITLE 2 T125(YB2/0) IN THE PRESENCE OF EDTA COMPND MOL_ID: 1; COMPND 2 MOLECULE: IG GAMMA-1 CHAIN C REGION; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 119-330; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IGHG1; SOURCE 6 EXPRESSION_SYSTEM: RATTUS NORVEGICUS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: RAT; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10116; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: (ATCC, CRL-1662) [T125(YB2/0)]; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: CMV PROMOTER; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PCI-NEO KEYWDS FC IGG1, FC-GAMMA RECEPTOR, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR R.MENEZ,E.A STURA,D.BOUREL,S.SIBERIL,S.JORIEUX,C.DE ROMEUF, AUTHOR 2 F.DUCANCEL,W.H.FRIDMAN,J.L.TEILLAUD REVDAT 4 13-SEP-23 3V95 1 HETSYN REVDAT 3 29-JUL-20 3V95 1 COMPND REMARK HETNAM SSBOND REVDAT 3 2 1 LINK SITE ATOM REVDAT 2 28-AUG-13 3V95 1 JRNL REVDAT 1 22-FEB-12 3V95 0 JRNL AUTH S.SIBERIL,R.MENEZ,S.JORIEUX,C.DE ROMEUF,D.BOUREL, JRNL AUTH 2 W.H.FRIDMAN,F.DUCANCEL,E.A.STURA,J.L.TEILLAUD JRNL TITL EFFECT OF ZINC ON HUMAN IGG1 AND ITS FC GAMMA R JRNL TITL 2 INTERACTIONS. JRNL REF IMMUNOL.LETT. V. 143 60 2012 JRNL REFN ISSN 0165-2478 JRNL PMID 22553781 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.89 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 14943 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.255 REMARK 3 R VALUE (WORKING SET) : 0.251 REMARK 3 FREE R VALUE : 0.321 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 787 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.69 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1040 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2930 REMARK 3 BIN FREE R VALUE SET COUNT : 55 REMARK 3 BIN FREE R VALUE : 0.4420 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3356 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 212 REMARK 3 SOLVENT ATOMS : 108 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 44.07 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.62000 REMARK 3 B22 (A**2) : 0.19000 REMARK 3 B33 (A**2) : 1.42000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 3.082 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.435 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.368 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 17.320 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.897 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.838 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3691 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5050 ; 1.795 ; 2.031 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 419 ; 7.437 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 151 ;33.681 ;24.967 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 582 ;22.281 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;22.166 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 595 ; 0.106 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2680 ; 0.008 ; 0.022 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2123 ; 0.753 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3489 ; 1.401 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1568 ; 1.565 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1561 ; 2.653 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3V95 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-DEC-11. REMARK 100 THE DEPOSITION ID IS D_1000069751. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-NOV-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00677 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15731 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 7.800 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : 0.10000 REMARK 200 FOR THE DATA SET : 17.5600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.69 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2 REMARK 200 DATA REDUNDANCY IN SHELL : 7.80 REMARK 200 R MERGE FOR SHELL (I) : 0.53800 REMARK 200 R SYM FOR SHELL (I) : 0.49100 REMARK 200 FOR SHELL : 3.780 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC 5.5.0109 REMARK 200 STARTING MODEL: PDB ENTRY 3V8C REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.83 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12.8% MPEG 5000, 21.5% ETHYLENE REMARK 280 GLYCOL, 0.002M EDTA, 0.1 M SODIUM CACODYLATE, PH 5.1, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.69000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.45500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.56000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 69.45500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.69000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.56000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 47.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 236 REMARK 465 GLY B 446 REMARK 465 LYS B 447 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN B 386 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 292 112.90 -19.18 REMARK 500 PRO A 374 -166.94 -75.33 REMARK 500 ILE A 377 158.81 177.88 REMARK 500 GLN A 419 -14.64 -43.90 REMARK 500 SER B 239 135.48 -32.66 REMARK 500 ASP B 265 35.82 38.94 REMARK 500 GLU B 272 85.37 -157.41 REMARK 500 HIS B 285 68.87 -163.56 REMARK 500 ARG B 292 176.45 -56.94 REMARK 500 ASN B 297 -166.07 -74.24 REMARK 500 SER B 324 88.93 -22.78 REMARK 500 LYS B 326 33.56 -76.41 REMARK 500 LYS B 334 111.38 -169.09 REMARK 500 THR B 359 39.95 -96.21 REMARK 500 PRO B 374 -168.21 -74.77 REMARK 500 GLN B 419 -58.73 -23.39 REMARK 500 ASN B 421 136.82 -28.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3V7M RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 REMARK 900 T125(YB2/0) IN THE PRESENCE OF ZN2+ REMARK 900 RELATED ID: 3V8C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 REMARK 900 T125(YB2/0) DOUBLE MUTANT (H310 AND H345 IN K) REMARK 900 RELATED ID: 2J6E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM REMARK 900 RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND REMARK 900 EVIDENCE FOR AFFINITY MATURATION REMARK 900 RELATED ID: 3FJT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED REMARK 900 SERUM HALF-LIFE DBREF 3V95 A 236 447 UNP P01857 IGHG1_HUMAN 119 330 DBREF 3V95 B 236 447 UNP P01857 IGHG1_HUMAN 119 330 SEQRES 1 A 212 GLY GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO LYS SEQRES 2 A 212 ASP THR LEU MET ILE SER ARG THR PRO GLU VAL THR CYS SEQRES 3 A 212 VAL VAL VAL ASP VAL SER HIS GLU ASP PRO GLU VAL LYS SEQRES 4 A 212 PHE ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA SEQRES 5 A 212 LYS THR LYS PRO ARG GLU GLU GLN TYR ASN SER THR TYR SEQRES 6 A 212 ARG VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP TRP SEQRES 7 A 212 LEU ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN LYS SEQRES 8 A 212 ALA LEU PRO ALA PRO ILE GLU LYS THR ILE SER LYS ALA SEQRES 9 A 212 LYS GLY GLN PRO ARG GLU PRO GLN VAL TYR THR LEU PRO SEQRES 10 A 212 PRO SER ARG ASP GLU LEU THR LYS ASN GLN VAL SER LEU SEQRES 11 A 212 THR CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE ALA SEQRES 12 A 212 VAL GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN TYR SEQRES 13 A 212 LYS THR THR PRO PRO VAL LEU ASP SER ASP GLY SER PHE SEQRES 14 A 212 PHE LEU TYR SER LYS LEU THR VAL ASP LYS SER ARG TRP SEQRES 15 A 212 GLN GLN GLY ASN VAL PHE SER CYS SER VAL MET HIS GLU SEQRES 16 A 212 ALA LEU HIS ASN HIS TYR THR GLN LYS SER LEU SER LEU SEQRES 17 A 212 SER PRO GLY LYS SEQRES 1 B 212 GLY GLY PRO SER VAL PHE LEU PHE PRO PRO LYS PRO LYS SEQRES 2 B 212 ASP THR LEU MET ILE SER ARG THR PRO GLU VAL THR CYS SEQRES 3 B 212 VAL VAL VAL ASP VAL SER HIS GLU ASP PRO GLU VAL LYS SEQRES 4 B 212 PHE ASN TRP TYR VAL ASP GLY VAL GLU VAL HIS ASN ALA SEQRES 5 B 212 LYS THR LYS PRO ARG GLU GLU GLN TYR ASN SER THR TYR SEQRES 6 B 212 ARG VAL VAL SER VAL LEU THR VAL LEU HIS GLN ASP TRP SEQRES 7 B 212 LEU ASN GLY LYS GLU TYR LYS CYS LYS VAL SER ASN LYS SEQRES 8 B 212 ALA LEU PRO ALA PRO ILE GLU LYS THR ILE SER LYS ALA SEQRES 9 B 212 LYS GLY GLN PRO ARG GLU PRO GLN VAL TYR THR LEU PRO SEQRES 10 B 212 PRO SER ARG ASP GLU LEU THR LYS ASN GLN VAL SER LEU SEQRES 11 B 212 THR CYS LEU VAL LYS GLY PHE TYR PRO SER ASP ILE ALA SEQRES 12 B 212 VAL GLU TRP GLU SER ASN GLY GLN PRO GLU ASN ASN TYR SEQRES 13 B 212 LYS THR THR PRO PRO VAL LEU ASP SER ASP GLY SER PHE SEQRES 14 B 212 PHE LEU TYR SER LYS LEU THR VAL ASP LYS SER ARG TRP SEQRES 15 B 212 GLN GLN GLY ASN VAL PHE SER CYS SER VAL MET HIS GLU SEQRES 16 B 212 ALA LEU HIS ASN HIS TYR THR GLN LYS SER LEU SER LEU SEQRES 17 B 212 SER PRO GLY LYS MODRES 3V95 ASN A 297 ASN GLYCOSYLATION SITE MODRES 3V95 ASN B 297 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET MAN C 3 11 HET MAN C 4 11 HET NAG C 5 14 HET GAL C 6 11 HET MAN C 7 11 HET NAG C 8 14 HET NAG D 1 14 HET NAG D 2 14 HET MAN D 3 11 HET MAN D 4 11 HET NAG D 5 14 HET GAL D 6 11 HET MAN D 7 11 HET NAG D 8 14 HET GOL A 509 6 HET GOL A 510 6 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM GOL GLYCEROL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 NAG 8(C8 H15 N O6) FORMUL 3 MAN 6(C6 H12 O6) FORMUL 3 GAL 2(C6 H12 O6) FORMUL 5 GOL 2(C3 H8 O3) FORMUL 7 HOH *108(H2 O) HELIX 1 1 LYS A 246 MET A 252 1 7 HELIX 2 2 LEU A 309 ASN A 315 1 7 HELIX 3 3 SER A 354 LEU A 358 5 5 HELIX 4 4 LYS A 414 GLN A 419 1 6 HELIX 5 5 LEU A 432 TYR A 436 5 5 HELIX 6 6 LYS B 246 MET B 252 1 7 HELIX 7 7 LEU B 309 ASN B 315 1 7 HELIX 8 8 SER B 354 LYS B 360 5 7 HELIX 9 9 LYS B 414 GLY B 420 1 7 HELIX 10 10 LEU B 432 TYR B 436 5 5 SHEET 1 A 4 SER A 239 PHE A 243 0 SHEET 2 A 4 GLU A 258 VAL A 266 -1 O THR A 260 N PHE A 243 SHEET 3 A 4 TYR A 300 THR A 307 -1 O VAL A 302 N VAL A 263 SHEET 4 A 4 LYS A 288 THR A 289 -1 N LYS A 288 O VAL A 305 SHEET 1 B 4 SER A 239 PHE A 243 0 SHEET 2 B 4 GLU A 258 VAL A 266 -1 O THR A 260 N PHE A 243 SHEET 3 B 4 TYR A 300 THR A 307 -1 O VAL A 302 N VAL A 263 SHEET 4 B 4 GLU A 293 GLU A 294 -1 N GLU A 293 O ARG A 301 SHEET 1 C 4 VAL A 282 VAL A 284 0 SHEET 2 C 4 LYS A 274 VAL A 279 -1 N VAL A 279 O VAL A 282 SHEET 3 C 4 TYR A 319 SER A 324 -1 O LYS A 320 N TYR A 278 SHEET 4 C 4 ILE A 332 ILE A 336 -1 O ILE A 336 N TYR A 319 SHEET 1 D 4 GLN A 347 LEU A 351 0 SHEET 2 D 4 GLN A 362 PHE A 372 -1 O LEU A 368 N TYR A 349 SHEET 3 D 4 PHE A 404 ASP A 413 -1 O LEU A 410 N LEU A 365 SHEET 4 D 4 TYR A 391 THR A 393 -1 N LYS A 392 O LYS A 409 SHEET 1 E 4 GLN A 347 LEU A 351 0 SHEET 2 E 4 GLN A 362 PHE A 372 -1 O LEU A 368 N TYR A 349 SHEET 3 E 4 PHE A 404 ASP A 413 -1 O LEU A 410 N LEU A 365 SHEET 4 E 4 VAL A 397 LEU A 398 -1 N VAL A 397 O PHE A 405 SHEET 1 F 4 GLN A 386 PRO A 387 0 SHEET 2 F 4 ALA A 378 SER A 383 -1 N SER A 383 O GLN A 386 SHEET 3 F 4 PHE A 423 MET A 428 -1 O SER A 426 N GLU A 380 SHEET 4 F 4 THR A 437 LEU A 441 -1 O LYS A 439 N CYS A 425 SHEET 1 G 2 GLU B 258 THR B 260 0 SHEET 2 G 2 VAL B 305 THR B 307 -1 O LEU B 306 N VAL B 259 SHEET 1 H 2 VAL B 263 SER B 267 0 SHEET 2 H 2 THR B 299 VAL B 302 -1 O VAL B 302 N VAL B 263 SHEET 1 I 4 VAL B 282 VAL B 284 0 SHEET 2 I 4 ASN B 276 VAL B 279 -1 N VAL B 279 O VAL B 282 SHEET 3 I 4 TYR B 319 LYS B 322 -1 O LYS B 320 N TYR B 278 SHEET 4 I 4 THR B 335 ILE B 336 -1 O ILE B 336 N TYR B 319 SHEET 1 J 4 GLN B 347 LEU B 351 0 SHEET 2 J 4 GLN B 362 PHE B 372 -1 O LYS B 370 N GLN B 347 SHEET 3 J 4 PHE B 404 ASP B 413 -1 O LEU B 410 N LEU B 365 SHEET 4 J 4 TYR B 391 THR B 393 -1 N LYS B 392 O LYS B 409 SHEET 1 K 4 GLN B 347 LEU B 351 0 SHEET 2 K 4 GLN B 362 PHE B 372 -1 O LYS B 370 N GLN B 347 SHEET 3 K 4 PHE B 404 ASP B 413 -1 O LEU B 410 N LEU B 365 SHEET 4 K 4 VAL B 397 LEU B 398 -1 N VAL B 397 O PHE B 405 SHEET 1 L 4 GLN B 386 PRO B 387 0 SHEET 2 L 4 ALA B 378 SER B 383 -1 N SER B 383 O GLN B 386 SHEET 3 L 4 PHE B 423 MET B 428 -1 O SER B 426 N GLU B 380 SHEET 4 L 4 THR B 437 LEU B 441 -1 O THR B 437 N VAL B 427 SSBOND 1 CYS A 261 CYS A 321 1555 1555 2.03 SSBOND 2 CYS A 367 CYS A 425 1555 1555 2.02 SSBOND 3 CYS B 261 CYS B 321 1555 1555 2.02 SSBOND 4 CYS B 367 CYS B 425 1555 1555 2.00 LINK ND2 ASN A 297 C1 NAG C 1 1555 1555 1.44 LINK ND2 ASN B 297 C1 NAG D 1 1555 1555 1.45 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O4 NAG C 2 C1 MAN C 3 1555 1555 1.44 LINK O6 MAN C 3 C1 MAN C 4 1555 1555 1.43 LINK O3 MAN C 3 C1 MAN C 7 1555 1555 1.44 LINK O2 MAN C 4 C1 NAG C 5 1555 1555 1.44 LINK O4 NAG C 5 C1 GAL C 6 1555 1555 1.45 LINK O2 MAN C 7 C1 NAG C 8 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.45 LINK O4 NAG D 2 C1 MAN D 3 1555 1555 1.46 LINK O6 MAN D 3 C1 MAN D 4 1555 1555 1.44 LINK O3 MAN D 3 C1 MAN D 7 1555 1555 1.45 LINK O2 MAN D 4 C1 NAG D 5 1555 1555 1.43 LINK O4 NAG D 5 C1 GAL D 6 1555 1555 1.44 LINK O2 MAN D 7 C1 NAG D 8 1555 1555 1.45 CISPEP 1 TYR A 373 PRO A 374 0 -5.17 CISPEP 2 TYR B 373 PRO B 374 0 -8.10 CRYST1 49.380 79.120 138.910 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020251 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012639 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007199 0.00000